6 trends tracked about this subject — the full history, oldest to newest below.
The FDA has approved Otsuka's new ADHD medication Simtriyo, introducing a triple reuptake inhibitor to the central nervous system market.
New reporting highlights how ADHD manifests differently in women, emphasizing the role of hormones and overlooked symptoms in diagnosis.
A new study indicates a connection between addictive social media consumption in adolescent boys and the emergence of ADHD symptoms.
New research ties slower maternal response to infants with higher ADHD risk in children
New research suggests a correlation between extended breastfeeding durations and a reduced risk of ADHD symptoms in children.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.